Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases

Experimental Neurology

Volumn 270, Issue , 2015, Pages 66-71

  Rodriguez Cruz, P M ^a   Huda, S ^a   Lopez Ruiz P ^a   Vincent, A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acetylcholine receptor; Agrin; Cell based assay; ColQ; LRP4; MuSK; Neuronal surface antibodies; Seronegative MG

Indexed keywords

AGRIN; AGRIN ANTIBODY; ANTIBODY; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; COLLAGEN Q ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 4 ANTIBODY; MUSCLE SPECIFIC KINASE ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY;

ALLERGIC ENCEPHALITIS; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; CELL BASED ASSAY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; MYASTHENIA GRAVIS; MYELOOPTIC NEUROPATHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; AUTOIMMUNE DISEASES; BIOASSAY; GENETIC TRANSFECTION; IMMUNOLOGY; PROCEDURES;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL ASSAY; HUMANS; MYASTHENIA GRAVIS; TRANSFECTION;

EID: 84929919878     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2015.01.011     Document Type: Article

References (36)

1. Arredondo J., Lara M., Ng F., Gochez D.A., Lee D.C., Logia S.P., Nguyen J., Maselli R.A. COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina. Hum. Genet. 2013, 10.1007/s00439-013-1391-3.
2. Bartoccioni E., Scuderi F., Minicuci G.M., Marino M., Ciaraffa F., Evoli A. Anti-MuSK antibodies: correlation with myasthenia gravis severity. Neurology 2006, 67:505-507. 10.1212/01.wnl.0000228225.23349.5d.
3. Cartaud A., Strochlic L., Guerra M., Blanchard B., Lambergeon M., Krejci E., Cartaud J., Legay C. MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction. J. Cell Biol. 2004, 165:505-515. 10.1083/jcb.200307164.
4. Carvajal-González A., Leite M.I., Water P., Woodhall M., Coutinho E., Balint B., Lang B., Pettingill P., Carr A., Sheerin U.M., Press R., Lunn M.P., Lim M., Maddison P., Meinck P., Vandenberghe W., Vincent A. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain 2014, 137:2178-2192.
5. Cossins J., Belaya K., Zoltowska K., Koneczny I., Maxwell S., Jacobson L., Leite M.I., Waters P., Vincent A., Beeson D. The search for new antigenic targets in myasthenia gravis. Ann. N. Y. Acad. Sci. 2012, 1275:123-128. 10.1111/j.1749-6632.2012.06833.x.
6. Devic P., Petiot P., Simonet T., Stojkovic T., Delmont E., Franques J., Magot A., Vial C., Lagrange E., Nicot A.S., Risson V., Eymard B., Schaeffer L. Antibodies to clustered acetylcholine receptor: expanding the phenotype. Eur. J. Neurol. 2014, 21:130-134. 10.1111/ene.12270.
7. Evoli A., Tonali P.A., Padua L., Monaco M.Lo, Scuderi F., Batocchi A.P., Marino M., Bartoccioni E. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003, 126:2304-2311. 10.1093/brain/awg223.
8. Gallardo E., Martínez-Hernández E., Titulaer M.J., Huijbers M.G., Martínez M.A., Ramos A., Querol L., Díaz-Manera J., Rojas-García R., Hayworth C.R., Verschuuren J.J., Balice-Gordon R., Dalmau J., Illa I. Cortactin autoantibodies in myasthenia gravis. Autoimmun. Rev. 2014, 13:1003-1007. 10.1016/j.autrev.2014.08.039.
9. Gasperi C., Melms A., Schoser B., Zhang Y., Meltoranta J., Risson V., Schaeffer L., Schalke B., Kröger S. Anti-agrin autoantibodies in myasthenia gravis. Neurology 2014, 82:1976-1983. 10.1212/WNL.0000000000000478.
10. Gresa-Arribas N., Titulaer M.J., Torrents A., Aguilar E., McCracken L., Leypoldt F., Gleichman A.J., Balice-Gordon R., Rosenfeld M.R., Lynch D., Graus F., Dalmau J. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014, 13:167-177. 10.1016/S1474-4422(13)70282-5.
11. Higuchi O., Hamuro J., Motomura M., Yamanashi Y. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann. Neurol. 2011, 69:418-422. 10.1002/ana.22312.
12. Irani S.R., Gelfand J.M., Al-Diwani A., Vincent A. Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann. Neurol. 2014, 76:168-184. 10.1002/ana.24200.
13. Jacob S., Viegas S., Leite M.I., Webster R., Cossins J., Kennett R., Hilton-Jones D., Morgan B.P., Vincent A. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis. Arch. Neurol. 2012, 69:994-1001. 10.1001/archneurol.2012.437.
14. Jarius S., Aboul-Enein F., Waters P., Kuenz B., Hauser A., Berger T., Lang W., Reindl M., Vincent A., Kristoferitsch W. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008, 131:3072-3080. 10.1093/brain/awn240.
15. Kawakami Y., Ito M., Hirayama M., Sahashi K., Ohkawara B., Masuda A., Nishida H., Mabuchi N., Engel A.G., Ohno K. Anti-MuSK autoantibodies block binding of collagen Q to MuSK. Neurology 2011, 77:1819-1826. 10.1212/WNL.0b013e318237f660.
16. Kawanami S., Tsuji R., Oda K. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis. Ann. Neurol. 1984, 15:195-200. 10.1002/ana.410150214.
17. Koneczny I., Cossins J., Waters P., Beeson D., Vincent A. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters. PLoS One 2013, 8:e80695. 10.1371/journal.pone.0080695.
18. Leite M.I., Jacob S., Viegas S., Cossins J., Clover L., Morgan B.P., Beeson D., Willcox N., Vincent A. IgG1 antibodies to acetylcholine receptors in "seronegative" myasthenia gravis y 1940-1952 2008, 10.1093/brain/awn092.
19. Leite M., Coutinho E., Lana-Peixoto M., Apostolos S., Waters P., Sato D., Graham A. Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 2012, 78:1601-1607.
20. Madhavan R., Gong Z.L., Ma J.J., Chan A.W.S., Peng H.B. The function of cortactin in the clustering of acetylcholine receptors at the vertebrate neuromuscular junction. PLoS One 2009, 4:e8478. 10.1371/journal.pone.0008478.
21. Newsom-Davis J., Pinching A.J., Vincent A., Wilson S.G. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 1978, 28:266-272.
22. Nitkin R.M., Smith M.A., Magill C., Fallon J.R., Yao Y.M., Wallace B.G., McMahan U.J. Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J. Cell Biol. 1987, 105:2471-2478.
23. Palace J., Leite I., Jacob A. A practical guide to the treatment of neuromyelitis optica. Pract. Neurol. 2012, 12:209-214. 10.1136/practneurol-2012-000237.
24. Pevzner A., Schoser B., Peters K., Cosma N.-C., Karakatsani A., Schalke B., Melms A., Kröger S. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J. Neurol. 2012, 259:427-435. 10.1007/s00415-011-6194-7.
25. Phillips W.D., Christadoss P., Losen M., Punga A.R., Shigemoto K., Verschuuren J., Vincent A. Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis. Exp. Neurol 2015, 270:28-39.
26. Schnell U., Dijk F., Sjollema K.A., Giepmans B.N.G. Immunolabeling artifacts and the need for live-cell imaging. Nat. Methods 2012, 9:152-158. 10.1038/nmeth.1855.
27. Shen C., Lu Y., Zhang B., Figueiredo D., Bean J., Jung J., Wu H., Barik A., Yin D.-M., Xiong W.-C., Mei L. Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis. J. Clin. Invest. 2013, 123:5190-5202. 10.1172/JCI66039.
28. Vincent A., Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J. Neurol. Neurosurg. Psychiatry 1985, 48:1246-1252.
29. Vincent A., Waters P., Leite M.I., Jacobson L., Koneczny I., Cossins J., Beeson D. Antibodies identified by cell-based assays in myasthenia gravis and associated diseases. Ann. N. Y. Acad. Sci. 2012, 1274:92-98. 10.1111/j.1749-6632.2012.06789.x.
30. Waters P.J., McKeon A., Leite M.I., Rajasekharan S., Lennon V.A., Villalobos A., Palace J., Mandrekar J.N., Vincent A., Bar-Or A., Pittock S.J. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012, 78:665-671. (discussion 669). 10.1212/WNL.0b013e318248dec1.
31. Waters P.J., Mckeon A., Rajasekharan S., Vincent A. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays 2012, 665-671.
32. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489. 10.1212/01.wnl.0000216139.44259.74.
33. Yang L., Maxwell S., Leite M.I., Waters P., Clover L., Fan X., Zhang D., Yang C., Beeson D., Vincent A. Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China. J. Neurol. Sci. 2011, 301:71-76. 10.1016/j.jns.2010.10.023.
34. Zandi M.S., Paterson R.W., Ellul M.A., Jacobson L., Al-Diwani A., Jones J.L., Cox A.L., Lennox B., Stamelou M., Bhatia K.P., Schott J.M., Coles A.J., Kullmann D.M., Vincent A. Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes. J. Neurol. Neurosurg. Psychiatry 2014, 10.1136/jnnp-2014-308736.
35. Zhang B., Tzartos J.S., Belimezi M., Ragheb S., Bealmear B., Lewis R.A., Xiong W.-C., Lisak R.P., Tzartos S.J., Mei L. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Arch. Neurol. 2012, 69:445-451. 10.1001/archneurol.2011.2393.
36. Zhang B., Shen C., Bealmear B., Ragheb S., Xiong W.-C., Lewis R.A., Lisak R.P., Mei L. Autoantibodies to agrin in myasthenia gravis patients. PLoS One 2014, 9:e91816. 10.1371/journal.pone.0091816.